Lv2
140 积分 2024-06-01 加入
Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration‐resistant nonmetastatic prostate cancer
2个月前
已完结
Silencing of ER-resident oxidoreductase PDIA3 inhibits malignant biological behaviors of multidrug-resistant gastric cancer
2个月前
已关闭
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
2个月前
已完结
Emergence of Neuroendocrine Tumors in Patients Treated with Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer: A Systematic Review and Meta-analysis
2个月前
已完结
Reticulophagy and viral infection
2个月前
已完结
Selective Actionable and Druggable Protein Kinases Drive the Progression of Neuroendocrine Prostate Cancer
2个月前
已完结
Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer
3个月前
已关闭
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
3个月前
已完结
Molecular mechanisms underlying the development of neuroendocrine prostate cancer
3个月前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
